To evaluate the in vivo relevance of our findings, we assessed the expression of hGV and CD66b (a marker of neutrophils) in human lung cancer and found a higher expression of hGV in neutrophil-infiltrated tumor lung tissue compared to non-tumor lung samples. The gene discussed is CEACAM8; the disease is lung carcinoma.